141 related articles for article (PubMed ID: 8508614)
1. Plasma concentrations of islet amyloid polypeptide after glucagon administration in type 2 diabetic patients and non-diabetic subjects.
van Jaarsveld BC; Hackeng WH; Lips CJ; Erkelens DW
Diabet Med; 1993 May; 10(4):327-30. PubMed ID: 8508614
[TBL] [Abstract][Full Text] [Related]
2. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
[TBL] [Abstract][Full Text] [Related]
3. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
[TBL] [Abstract][Full Text] [Related]
4. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
[TBL] [Abstract][Full Text] [Related]
5. No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes.
Ahrén B; Gutniak M
Eur J Endocrinol; 1997 Dec; 137(6):643-9. PubMed ID: 9437230
[TBL] [Abstract][Full Text] [Related]
6. Effect of insulin treatment on circulating islet amyloid polypeptide in patients with NIDDM.
Lindström T; Leckström A; Westermark P; Arnqvist HJ
Diabet Med; 1997 Jun; 14(6):472-6. PubMed ID: 9212313
[TBL] [Abstract][Full Text] [Related]
7. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
Tomita T
Islets; 2012; 4(3):223-32. PubMed ID: 22847497
[TBL] [Abstract][Full Text] [Related]
8. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
[TBL] [Abstract][Full Text] [Related]
9. An improved method for the determination of islet amyloid polypeptide levels in plasma.
van Hulst KL; Hackeng WH; Höppener JW; van Jaarsveld BC; Nieuwenhuis MG; Blankenstein MA; Lips CJ
Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():165-70. PubMed ID: 8060096
[TBL] [Abstract][Full Text] [Related]
10. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.
Sanke T; Hanabusa T; Nakano Y; Oki C; Okai K; Nishimura S; Kondo M; Nanjo K
Diabetologia; 1991 Feb; 34(2):129-32. PubMed ID: 2065848
[TBL] [Abstract][Full Text] [Related]
11. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients.
Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S
Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232
[TBL] [Abstract][Full Text] [Related]
12. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
Iki K; Pour PM
J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism.
Valdermarsson S; Leckström A; Westermark P; Bergenfelz A
Eur J Endocrinol; 1996 Mar; 134(3):320-5. PubMed ID: 8616529
[TBL] [Abstract][Full Text] [Related]
14. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
Permert J; Larsson J; Westermark GT; Herrington MK; Christmanson L; Pour PM; Westermark P; Adrian TE
N Engl J Med; 1994 Feb; 330(5):313-8. PubMed ID: 8277951
[TBL] [Abstract][Full Text] [Related]
15. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.
Tomita T
Islets; 2011; 3(4):166-74. PubMed ID: 21633185
[TBL] [Abstract][Full Text] [Related]
17. Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals.
Westermark P; Wilander E; Westermark GT; Johnson KH
Diabetologia; 1987 Nov; 30(11):887-92. PubMed ID: 3328723
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to islet amyloid polypeptide in diabetes.
Clark A; Yon SM; de Koning EJ; Holman RR
Diabet Med; 1991; 8(7):668-73. PubMed ID: 1833120
[TBL] [Abstract][Full Text] [Related]
19. [Postpartum evaluation of amylin secretion in gestational diabetes mellitus].
Kinalski M; Sledziewski A; Telejko B; Mironczuk K; Kretowski A; Kinalska I
Med Wieku Rozwoj; 2002; 6(1):75-80. PubMed ID: 12177515
[TBL] [Abstract][Full Text] [Related]
20. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
